Valeria Barcella

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study.

Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study.

Journal: Multiple sclerosis and related disorders

Published: July 23, 2024

Brain structural abnormalities and cognitive changes in a patient with 17q21.31 microduplication and early onset dementia: a case report.

Brain structural abnormalities and cognitive changes in a patient with 17q21.31 microduplication and early onset dementia: a case report.

Journal: Journal of neurology

Published: September 22, 2022

Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.

Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.

Journal: Journal of neuroimmunology

Published: September 13, 2022

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2022

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

Journal: Journal of neurology

Published: January 14, 2021

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 17, 2020

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 17, 2020

Cladribine vs other drugs in MS: Merging randomized trial with real-life data.

Cladribine vs other drugs in MS: Merging randomized trial with real-life data.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 27, 2020

Impact of natural menopause on multiple sclerosis: a multicentre study.

Impact of natural menopause on multiple sclerosis: a multicentre study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 08, 2019

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

Journal: Journal of neurology

Published: August 30, 2018

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 26, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026